INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $158,000 | +9.0% | 7,341 | 0.0% | 0.01% | -68.6% |
| Q2 2022 | $145,000 | -16.2% | 7,341 | 0.0% | 0.04% | +6.1% |
| Q1 2022 | $173,000 | -13.5% | 7,341 | 0.0% | 0.03% | -2.9% |
| Q4 2021 | $200,000 | -7.0% | 7,341 | -6.0% | 0.03% | -10.5% |
| Q3 2021 | $215,000 | -3.2% | 7,813 | 0.0% | 0.04% | +8.6% |
| Q2 2021 | $222,000 | -16.5% | 7,813 | 0.0% | 0.04% | -22.2% |
| Q1 2021 | $266,000 | +2.3% | 7,813 | 0.0% | 0.04% | +2.3% |
| Q4 2020 | $260,000 | +3.6% | 7,813 | 0.0% | 0.04% | -6.4% |
| Q3 2020 | $251,000 | +16.7% | 7,813 | 0.0% | 0.05% | +20.5% |
| Q2 2020 | $215,000 | +156.0% | 7,813 | +48.3% | 0.04% | +116.7% |
| Q1 2020 | $84,000 | -33.3% | 5,270 | 0.0% | 0.02% | -21.7% |
| Q4 2019 | $126,000 | +35.5% | 5,270 | 0.0% | 0.02% | +27.8% |
| Q3 2019 | $93,000 | -31.1% | 5,270 | 0.0% | 0.02% | -25.0% |
| Q2 2019 | $135,000 | – | 5,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |